Koch Enterprises
1
13M
1
0.01
- Areas of investment
Summary
In 1873 was created Koch Enterprises, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Evansville.
The typical case for the fund is to invest in rounds with 6 participants. The meaningful sponsors for the fund in investment in the same round are The Aurora Funds, Noro-Moseley Partners, Mitsui Global Investment.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2002.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Norak Biosciences. Among the most popular fund investment industries, there are Life Science, Pharmaceutical.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.01
- Investments by industry
- Pharmaceutical (1)
- Life Science (1)
- Biotechnology (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2002
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Norak Biosciences | 05 Feb 2002 | Biotechnology, Life Science, Pharmaceutical | Early Stage Venture | 13M | United States, North Carolina |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.